Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry Into the Pharmaceutical Markets

Fatokun, Omotayo

doi:10.1016/b978-0-12-811228-1.00013-3

Social and Administrative Aspects of Pharmacy in Low- And Middle-Income Countries 2018

DOI: 10.1016/b978-0-12-811228-1.00013-3

|View full text |Cite

Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry Into the Pharmaceutical Markets

Omotayo Fatokun

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The determinants and characteristics of generic medicines entry following the patent expiration of innovator drug products in Malaysia were investigated. The sources of data used for the work included 22 policy documents, a survey of 13 key informants, a cross-sectional questionnaire of 14 generic medicines manufacturing industries, and panel data analysis of the 12 best-selling single entity prescription drug products that experienced loss of patent protection and subsequent generics entry in Malaysia between January 2001 and December 2009 [4].…”

mentioning

confidence: 99%

Generic medicines entry into the Malaysian pharmaceutical market

Fatokun¹,

Ibrahim²,

Hassaii³

2016

GaBI J

Self Cite

View full text Add to dashboard Cite

The presence of generic drugs in a market is of great importance to society as it increases competition between suppliers of these products, which can lead to a reduction in the price of already established drugs. In the late 1990s there were relevant regulatory changes in the Brazilian pharmaceutical sector, which allowed for a gradual increase in the share of generic drugs in the domestic market. This paper aims to document the entry pattern of generic drug suppliers in Brazil after the arrival of the first generic manufacturer in the domestic market. Using a sample of 1228 observations involving 148 different drugs (active ingredients), we investigated the relationship between the number of periods after the arrival of the first generic drug supplier in Brazil and the number of suppliers of genetic drugs with the same active ingredient. We find that there was a continuous entry of generic suppliers after the first generic in the market. However, this increase in suppliers occurs at decreasing rates.

show abstract

mentioning

confidence: 99%

Generic medicines entry into the Malaysian pharmaceutical market

Fatokun¹,

Ibrahim²,

Hassaii³

2016

GaBI J

Self Cite

View full text Add to dashboard Cite

show abstract

Impact of pharmaceutical price controls on the cost of cardiovascular drugs: does essentiality matter?

Khanijo

Kakkar

Kumar

et al. 2020

Expert Review of Clinical Pharmacology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry Into the Pharmaceutical Markets

Cited by 2 publications

References 36 publications

Generic medicines entry into the Malaysian pharmaceutical market

Generic medicines entry into the Malaysian pharmaceutical market

Impact of pharmaceutical price controls on the cost of cardiovascular drugs: does essentiality matter?

Contact Info

Product

Resources

About